Login to Your Account



Painreform seeks new deal on pain management product

By Cormac Sheridan
Staff Writer

Wednesday, February 12, 2014
With preliminary phase IIa data in hand for its postoperative pain treatment PRF-110, Israeli specialty pharmaceutical firm Painreform Ltd. is now seeking takers for the product, which has a 505(b)(2) approval pathway in the U.S.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription